Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

276
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.

JAMA oncology·2026
Same author

ASO Visual Abstract: From Clinical Trial Awareness to Practice-Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial.

Annals of surgical oncology·2026
Same author

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Multidisciplinary clinics in cancer-models, metrics, and meaning: a review.

The oncologist·2026
Same author

Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort.

JNCI cancer spectrum·2026
Same author

ASO Visual Abstract: Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age.

Annals of surgical oncology·2026
Same journal

Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular Carcinoma.

Annals of surgical oncology·2026
Same journal

ASO Author Reflections: The Hidden Cost of Gastric Preservation During Cytoreductive Surgery for Pseudomyxoma Peritonei: Understanding the Functional Consequences of Extensive Perigastric Cytoreduction.

Annals of surgical oncology·2026
Same journal

Survival of Squamous Cell Carcinoma Versus Adenocarcinoma in Resected Stage I-III Non-small Cell Lung Cancer.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Quality, Reliability, and Viewer Engagement of YouTube Videos on Esophageal Cancer: A Cross-Sectional Study.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same journal

Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.

Annals of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions.

Anika Shah1, Jordan A Love1,2, Matthew Butler1,2,3

  • 1Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Annals of Surgical Oncology
|March 13, 2026
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) can extract breast cancer sentinel lymph node (SLN) metastasis data but need specific prompts for accurate risk prediction. Current AI automation for nomogram-based risk may not outweigh optimization costs.

Keywords:
Artificial intelligenceBreast cancerNomogramsRisk prediction

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

988
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842

Related Experiment Videos

Last Updated: Mar 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

988
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

842

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Sentinel lymph node (SLN) metastasis nomograms aid early-stage breast cancer surgical decisions.
  • Nomogram use is limited by the effort required for variable review and input.
  • This study investigates the utility of large language models (LLMs) for SLN metastasis risk prediction.

Purpose of the Study:

  • To evaluate OpenAI's LLMs' ability to extract data for nomogram use.
  • To assess LLM performance in reproducing SLN metastasis rates using established nomograms.
  • To compare AI-generated risk estimates with physician-derived predictions.

Main Methods:

  • De-identified radiology and pathology notes from 20 early-stage breast cancer patients were analyzed.
  • Three LLM prompting strategies were tested, including direct estimation, nomogram use, and chain-of-thought reasoning.
  • AI-generated SLN metastasis risk predictions were compared against manual physician calculations.

Main Results:

  • OpenAI o1 extracted all clinical variables in 65-80% of cases, with tumor size frequently misidentified.
  • Initial LLM-physician agreement on risk prediction was low (0-10% exact matches), indicating moderate reliability (ICC, 0.57-0.62).
  • An optimized GPT-4o prompt significantly improved agreement (25% exact matches, 90% near agreement) and reliability (ICC, 0.95).

Conclusions:

  • LLMs can extract necessary nomogram inputs from clinical notes.
  • Task-specific prompt engineering is crucial for accurate AI-driven SLN metastasis risk estimation.
  • Current AI automation for nomogram-based risk prediction may require substantial resources for optimization.